BRPI1013509A2 - método e composição para melhorar a absorção de agentes terapêuticos - Google Patents

método e composição para melhorar a absorção de agentes terapêuticos

Info

Publication number
BRPI1013509A2
BRPI1013509A2 BRPI1013509A BRPI1013509A BRPI1013509A2 BR PI1013509 A2 BRPI1013509 A2 BR PI1013509A2 BR PI1013509 A BRPI1013509 A BR PI1013509A BR PI1013509 A BRPI1013509 A BR PI1013509A BR PI1013509 A2 BRPI1013509 A2 BR PI1013509A2
Authority
BR
Brazil
Prior art keywords
composition
therapeutic agents
improving absorption
absorption
improving
Prior art date
Application number
BRPI1013509A
Other languages
English (en)
Inventor
Ashish B Patel
Eric R First
Guido Schmitz
Hung-Huar Tong
Stephanie Petaway-Hickson
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43062708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1013509(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of BRPI1013509A2 publication Critical patent/BRPI1013509A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1013509A 2009-05-11 2010-05-10 método e composição para melhorar a absorção de agentes terapêuticos BRPI1013509A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/387,977 US11135188B2 (en) 2009-05-11 2009-05-11 Method and composition to improve absorption of therapeutic agents
PCT/US2010/001375 WO2010132095A1 (en) 2009-05-11 2010-05-10 Method and composition to improve absorption of therapeutic agents

Publications (1)

Publication Number Publication Date
BRPI1013509A2 true BRPI1013509A2 (pt) 2016-04-05

Family

ID=43062708

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013509A BRPI1013509A2 (pt) 2009-05-11 2010-05-10 método e composição para melhorar a absorção de agentes terapêuticos

Country Status (15)

Country Link
US (1) US11135188B2 (pt)
EP (1) EP2429502B1 (pt)
AR (1) AR076864A1 (pt)
BR (1) BRPI1013509A2 (pt)
CA (1) CA2761678A1 (pt)
CL (1) CL2011002807A1 (pt)
CO (1) CO6460753A2 (pt)
EA (1) EA201171399A1 (pt)
HU (1) HUE043173T2 (pt)
MX (1) MX2011011928A (pt)
PL (1) PL2429502T3 (pt)
PT (1) PT2429502T (pt)
SI (1) SI2429502T1 (pt)
UY (1) UY32624A (pt)
WO (1) WO2010132095A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
LT2953617T (lt) * 2013-02-06 2020-01-10 Hermes Arzneimittel Gmbh Farmacinės kompozicijos, apimančios mažų dozių vaistus
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3154528B1 (en) 2014-06-11 2023-04-05 SpecGx LLC Spray dried compositions having different dissolution profiles and processes for their preparation
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
EP4243781A1 (en) * 2020-11-13 2023-09-20 Bayer HealthCare, LLC Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof
CN118638044A (zh) * 2023-03-13 2024-09-13 南京济群医药科技股份有限公司 一种快速释放的琥珀酸多西拉敏组合物及其制备方法
US12594249B2 (en) * 2023-06-02 2026-04-07 Thermolife International, Llc Soluble curcumin and its derivatives
MX2023011800A (es) 2023-10-05 2025-05-02 Laboratorios Silanes S A De C V Combinacion de celecoxib - acetaminofen de estabilidad mejorada y procedimiento para su preparacion

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191225486A (en) 1912-11-06 1913-04-24 Herbert Sefton-Jones Manufacture and Production of Improved Pharmaceutical Preparations.
US2293359A (en) 1941-01-08 1942-08-18 Quisling Sverre Acetyl salicylic acid preparation
FI89004C (fi) 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
RU2099058C1 (ru) 1992-06-15 1997-12-20 Институт химии твердого тела и переработки минерального сырья СО РАН Способ получения твердой быстрорастворимой дисперсной системы, содержащей ацетилсалициловую кислоту
US5665388A (en) 1995-11-13 1997-09-09 Health Corporation Method for preparation of an alkaline and aspirin combination compound
KR20010023256A (ko) 1997-08-27 2001-03-26 헥살 아게 용해도와 생체 이용성이 개선된 신규의 멜록시캄 의약조성물
US8231899B2 (en) * 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
RU2170582C1 (ru) 2000-02-17 2001-07-20 Институт химии твердого тела и механохимии СО РАН Способ получения быстрорастворимой таблетированной формы ацетилсалициловой кислоты
WO2005105102A1 (en) 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
BRPI0508063A (pt) * 2004-06-29 2007-07-17 Nycomed Danmark Aps processo para a manufatura de uma composição farmacêutica, nsaid, e, composição farmacêutica
WO2006047493A2 (en) * 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents

Also Published As

Publication number Publication date
HUE043173T2 (hu) 2019-08-28
EP2429502A4 (en) 2012-10-24
PT2429502T (pt) 2019-03-29
WO2010132095A8 (en) 2011-07-07
MX2011011928A (es) 2011-12-06
UY32624A (es) 2010-12-31
EP2429502A1 (en) 2012-03-21
EA201171399A1 (ru) 2012-05-30
PL2429502T3 (pl) 2019-07-31
SI2429502T1 (sl) 2019-05-31
US20100286100A1 (en) 2010-11-11
CA2761678A1 (en) 2010-11-18
CL2011002807A1 (es) 2012-06-15
WO2010132095A1 (en) 2010-11-18
AR076864A1 (es) 2011-07-13
US11135188B2 (en) 2021-10-05
EP2429502B1 (en) 2018-12-26
CO6460753A2 (es) 2012-06-15

Similar Documents

Publication Publication Date Title
PT2448582T (pt) Compostos e composições terapêuticas
BR112013007678A2 (pt) método para tratamento de doenças alérgicas
BRPI0911426A2 (pt) ferramentas terapêuticas e métodos para tratar cegueira
PT2515855E (pt) Terapêutica de combinação para dpoc
BRPI0914614A2 (pt) 2-arilaminoquinazolinas para tratar doenças proliferativas
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
DK2361116T3 (da) Bestrålingsindretning
DK2408807T3 (da) Fremgangsmåde til terapeutisk anvendelse
BRPI1012638A2 (pt) métodos e intermediários para preparar agentes farmacêuticos
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
PT2340042E (pt) Métodos e composições para o tratamento de cancro
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
PL3721880T3 (pl) Kompozycja i sposób naprawy i regeneracji mięśni
PT2512502T (pt) Métodos e composições para supressão de tumores
PT2429502T (pt) Método e composição para melhorar a absorção de aspirina
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0923534A2 (pt) composição e método para tratamento de doenças de pele
BR112012004836A2 (pt) pirazinilpiridinas úteis para o tratamento de doenças proliferativas
BRPI0917684A2 (pt) método terapêutico homeopático
PT2718434T (pt) Composições e métodos para tratar a doença de espru celíaco
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
BRPI1009141A2 (pt) composições e métodos para profilaxia e tratamento de vícios

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]